Meddenovo Drug Design

Meddenovo Drug Design leverages AI, molecular modeling, and cyclic peptides to create innovative therapeutic solutions. Their platform is uniquely designed to harness the potential of cyclic peptides, aiming to accelerate drug development and reduce time to market for treatments of diseases like cancer and autoimmune disorders.

Buy Funded Startups lists

Funding Round: Pre-Seed

Funding Amount: €1M

Date: 31-Jul-2024

Investors: ACT Venture Partners

Markets: Biotech, Pharmaceuticals, AI, Drug Discovery, Biotechnology Research

HQ: Villeurbanne, Auvergne-Rhône-Alpes, France

Founded: 2021

Website: https://meddenovo.com/

LinkedIn: https://www.linkedin.com/company/meddenovo-drug-design

Twitter:

Instagram: